NICE RESTRICTIVENESS COMPARED TO THE MARKET AUTHORIZATION IN ONCOLOGY AND NON-ONCOLOGY REVIEWS
Author(s)
Jaksa A, Westbrook L, Rubinstein E, Daniel K, Ho YS
Context Matters, Inc., New York, NY, USA
OBJECTIVES: To determine how often NICE recommendations are more restrictive than market authorizations in oncology reviews compared to non-oncology reviews. METHODS:
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PCN263
Topic
Health Technology Assessment
Topic Subcategory
Decision & Deliberative Processes
Disease
Multiple Diseases, Oncology